This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Wan TSK, Ma SK, CK Li, Chan LC . Atypical fluorescence in-situ hybridization (FISH) pattern in chronic myeloid leukaemia (CML) due to cryptic insertion of BCR at 9q34. Leukemia 2003; 18: 161–162.
Primo D, Tabernero MD, Rasillo A, Sayagues JM, Espinosa AB, Chillon MC et al. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities. Leukemia 2003; 17: 1124–1129.
Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P et al. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 2001; 98: 1732–1738.
Vieira L, Alves AC, Marques B, Reis I, Jorge G, Ambrosio AP et al. Insertion of the 5′ part of BCR within the ABL gene at 9q34 in a Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet 1999; 114: 17–21.
Abruzzese E, Pettenati MJ, Cox K, Jackle B, Watts RG, Carroll AJ et al. Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases. Cancer Genet Cytogenet 1998; 105: 164–167.
Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers GJ, Van der Plas D et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer 1993; 8: 237–245.
Reddy KS, Grove B . A Philadelphia-negative chronic myeloid leukemia with a BCR/ABL fusion gene on chromosome 9. Cancer Genet Cytogenet 1998; 107: 48–50.
Storlazzi CT, Anelli L, Surace C, Lonoce A, Zagaria A, Nanni M et al. Molecular cytogenetic characterization of a complex rearrangement involving chromosomes 9 and 22 in a case of Ph-negative chronic myeloid leukemia. Cancer Genet Cytogenet 2002; 136: 141–145.
van der Plas DC, Grosveld G, Hagemeijer A . Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet Cytogenet 1991; 52: 143–156.
Inazawa J, Nishigaki H, Takahira H, Nishimura J, Horiike S, Taniwaki M et al. Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemia. Hum Genet 1989; 83: 115–118.
Morris CM, Heisterkamp N, Kennedy MA, Fitzgerald PH, Groffen J . Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22. Blood 1990; 76: 1812–1818.
Nacheva E, Holloway T, Brown K, Bloxham D, Green AR . Philadelphia-negative chronic myeloid leukaemia: detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22. Br J Haematol 1994; 87: 409–412.
Abeliovich D, Yehuda O, Krichevsky S, Nagler A, Ben-Neriah S, Werner M et al. Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia. Cancer Genet Cytogenet 1995; 81: 115–117.
Brunel V, Sainty D, Costello R, Mozziconacci MJ, Simonetti J, Arnoulet C et al. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet 1995; 85: 82–84.
Takahashi N, Miura I, Ohshima A, Utsumi S, Nimura T, Hashimoto K et al. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia. Cancer Genet Cytogenet 1996; 89: 166–169.
Macera MJ, Smith LJ, Frankel E, Szabo P, Verma RS . A Philadelphia negative chronic myelogenous leukemia with the chimeric BCR/ABL gene on chromosome 9 and a b3-a2 splice junction. Cancer Genet Cytogenet 1998; 101: 143–147.
Hsu WT, Preisler H, Szego K, Sprudzs R, Gao XZ . The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: a case for vigilance in fluorescence in situ hybridization interpretation. Cancer Genet Cytogenet 1998; 104: 57–60.
Yehuda O, Abeliovich D, Ben-Neriah S, Sverdlin I, Cohen R, Varadi G et al. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive. Cancer Genet Cytogenet 1999; 114: 100–107.
Aurich J, Dastugue N, Duchayne E, Schlaifer D, Rigal-Huguet F, Caballin MR . Location of the BCR-ABL fusion gene on the 9q34 band in two cases of Ph-positive chronic myeloid leukemia. Genes Chromosomes Cancer 1997; 20: 148–154.
Mohamed AN, Koppitch F, Varterasian M, Karanes C, Yao KL, Sarkar FH . BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome. Genes Chromosomes Cancer 1995; 13: 133–137.
Zhang Y, Weber-Matthiesen K, Schoch R, Schlegelberger B . Variant Philadelphia translocation t (9;17)(q34.2-3;q21.3) with colocalization of the BCR and ABL genes on chromosome 9 in chronic myeloid leukemia. Cancer Genet Cytogenet 1997; 96: 87–89.
Sessarego M, Fugazza G, Bruzzone R, Ballestrero A, Miglino M, Bacigalupo A . Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11. Haematologica 2000; 85: 35–39.
Reddy KS, Sulcova V . A FISH study of variant Philadelphia rearrangements. Cancer Genet Cytogenet 2000; 118: 121–131.
Costa D, Espinet B, Queralt R, Carrio A, Sole F, Colomer D et al. Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia. Cancer Genet Cytogenet 2003; 141: 114–119.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Primo, D., Tabernero, M., Espinosa, A. et al. Reply to Wan et al. Leukemia 18, 162–164 (2004). https://doi.org/10.1038/sj.leu.2403198
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403198